Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr
News

Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr

The company has posted net profit of Rs. 55.36 crores for the Financial Year ended March 31, 2025

  • By IPP Bureau | May 12, 2025

Jagsonpal Pharmaceuticals Ltd has reported Standalone financial results for the period ended March 31, 2025. 

Jagsonpal Pharmaceuticals has posted net profit of Rs. 6.58 crores for the period ended March 31, 2025 as against net profit of Rs. 31.99 crores for the period ended December 31, 2024. The company posted net profit of Rs. 3.54 crores for the period ended March 31, 2024. 

Jagsonpal Pharmaceuticals has reported total income of Rs. 61.33 crores during the period ended March 31, 2025 as compared to Rs. 76.34 crores during the period ended December 31, 2024. The company reported total income of Rs.45.97 crores during the period ended March 31, 2024. 

For the Financial Year ended March 31, 2025, Jagsonpal Pharmaceuticals has reported total income of Rs. 276.90 crores as compared to Rs. 217.981 crores during the Financial Year ended March 31, 2024. 

The company has posted net profit of Rs. 55.36 crores for the Financial Year ended March 31, 2025 as against net profit of Rs. 22.46 crores for the Financial Year ended March 31, 2024.

Upcoming E-conference

Other Related stories

Startup

Digitization